Evidence map›Paper›PMID 38586125›Full record

ArticleTranslational and clinical pharmacology2024

The effects of opium consumption on severity of disease on hospitalized COVID-19 patients in East of Iran, a prospective cohort study.

Abdol Satar Pagheh, Toba Kazemi, Seyed Mohammad Riahi, Mohammad Karimi, Moloud Foogerdi, Anahita Arian, Shima Heydari, Mohammad Yousef Ghoddousi, Parisa Vahdati, Mohammad Reza Khazdair

Abstract read
In one paragraph

Article in Translational and clinical pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abdol Satar PaghehInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.ORCID https://orcid.org/0000-0002-1234-6127
Toba KazemiCardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.ORCID https://orcid.org/0000-0002-6204-4514
Seyed Mohammad RiahiCardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.ORCID https://orcid.org/0000-0002-3184-2126
Mohammad KarimiDepartment of Emergency Medicine, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.ORCID https://orcid.org/0000-0001-6454-2747
Moloud FoogerdiDepartment of Emergency Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.ORCID https://orcid.org/0000-0002-5476-4001
Anahita ArianCardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.ORCID https://orcid.org/0000-0001-9109-2526
Shima HeydariDepartment of Internal Medicine, School of Medicine, Torbat Heydariyeh University of Medical Sciences, Torbat Heydarieh, Iran.ORCID https://orcid.org/0000-0002-7682-3084
Mohammad Yousef GhoddousiCardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.ORCID https://orcid.org/0000-0002-8937-1857
Parisa VahdatiInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.ORCID https://orcid.org/0009-0004-6957-6208
Mohammad Reza KhazdairCardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.ORCID https://orcid.org/0000-0001-9854-6121

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are few theories and little empirical evidence about the bilateral impact of substance use and coronavirus disease 2019 (COVID-19), so a logical and accurate picture of this area is required. We investigated the effects of opium use on severity of disease on hospitalized COVID-19 patients in east of Iran. Demographic and clinical characteristics, vital signs, laboratory tests, mortality rate, type and duration of opium consumption in hospitalized patients who recovered from COVID-19 in the follow-up after 3 months were evaluated. In this study, 60 (20%) participants were the opium user and 251 (80%) were the non-user patients. Based on clinical symptoms, hypertension and systolic blood pressure in opium user were significantly higher than non-user patients (

Indexed as

Communicable DiseasesCOVID-19Disease SeverityOpium PoppyPapaver somniferum

Identifiers

PMID38586125
PMCPMC10990726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.